{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T03:14:12Z","timestamp":1773803652236,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-05610-5","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T06:15:36Z","timestamp":1770790536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correlation between pharmacologic blood pressure\u2013lowering intensity and improvement in cardiac function in patients with acutely decompensated heart failure"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhe","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeyuan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"issue":"4","key":"5610_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/ejhf.57","volume":"16","author":"KF AlHabib","year":"2014","unstructured":"AlHabib KF, Elasfar AA, Alfaleh H, et al. Clinical features, management, and short- and long\u2010term outcomes of patients with acute decompensated heart failure: phase I results of the HEARTS database. Eur J Heart Fail. 2014;16(4):461\u20139. https:\/\/doi.org\/10.1002\/ejhf.57.","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"5610_CR2","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.3390\/jcm12155090","volume":"12","author":"F Triposkiadis","year":"2023","unstructured":"Triposkiadis F, Sarafidis P, Briasoulis A, et al. Hypertensive heart failure. J Clin Med. 2023;12(15):5090. https:\/\/doi.org\/10.3390\/jcm12155090.","journal-title":"J Clin Med"},{"issue":"2","key":"5610_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ccl.2021.12.011","volume":"40","author":"KE Di Palo","year":"2022","unstructured":"Di Palo KE, Barone NJ. Hypertension and heart failure. Cardiol Clin. 2022;40(2):237\u201344. https:\/\/doi.org\/10.1016\/j.ccl.2021.12.011.","journal-title":"Cardiol Clin"},{"issue":"2","key":"5610_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijcard.2010.04.003","volume":"144","author":"M Metra","year":"2010","unstructured":"Metra M, Felker GM, Zac\u00e0 V, et al. Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. Int J Cardiol. 2010;144(2):175\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2010.04.003.","journal-title":"Int J Cardiol"},{"key":"5610_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/IJNRD.S185988","volume":"12","author":"J Iglesias","year":"2019","unstructured":"Iglesias J, Ghetiya S, Ledesma KJ, Patel CS, Levine JS. Interactive and potentially independent roles of renin-angiotensin-aldosterone system Blockade and the development of cardiorenal syndrome, type 1 on in-hospital mortality among elderly patients admitted with acute decompensated congestive heart failure. Int J Nephrol Renov Dis. 2019;12:33\u201348. https:\/\/doi.org\/10.2147\/IJNRD.S185988.","journal-title":"Int J Nephrol Renov Dis"},{"issue":"11","key":"5610_CR6","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.3390\/jcm9113384","volume":"9","author":"M Gaubert","year":"2020","unstructured":"Gaubert M, Laine M, Resseguier N, et al. Hemodynamic profiles of cardiogenic shock depending on their etiology. J Clin Med. 2020;9(11):3384. https:\/\/doi.org\/10.3390\/jcm9113384.","journal-title":"J Clin Med"},{"issue":"6","key":"5610_CR7","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1161\/HYPERTENSIONAHA.121.16503","volume":"77","author":"K Raby","year":"2021","unstructured":"Raby K, Rocco M, Oparil S, Gilbert ON, Upadhya B. Heart failure primary prevention: what does SPRINT add? Recent advances in hypertension. Hypertension. 2021;77(6):1804\u201314. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.16503.","journal-title":"Hypertension"},{"issue":"9","key":"5610_CR8","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1253\/circj.CJ-19-0333","volume":"83","author":"Y Arao","year":"2019","unstructured":"Arao Y, Sawamura A, Nakatochi M, et al. Early blood pressure reduction by intravenous vasodilators is associated with acute kidney injury in patients with hypertensive acute decompensated heart. Circ J. 2019;83(9):1883\u201390. https:\/\/doi.org\/10.1253\/circj.CJ-19-0333.","journal-title":"Circ J"},{"issue":"12","key":"5610_CR9","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jash.2016.10.005","volume":"10","author":"PD Levy","year":"2016","unstructured":"Levy PD, Willock RJ, Burla M, et al. Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction. J Am Soc Hypertens. 2016;10(12):906\u201316. https:\/\/doi.org\/10.1016\/j.jash.2016.10.005.","journal-title":"J Am Soc Hypertens"},{"key":"5610_CR10","doi-asserted-by":"publisher","unstructured":"Tiepolo A, Nougu\u00e9 H, Damoisel C, Launay JM, Vodovar N, Mebazaa A. Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril\/Valsartan: a case report. Tan TC, Galyavich A, Aboumarie HS, Camm CF, Thomson R, eds. Eur Heart J - Case Rep. 2019;3(3):ytz108. https:\/\/doi.org\/10.1093\/ehjcr\/ytz108.","DOI":"10.1093\/ehjcr\/ytz108"},{"issue":"6","key":"5610_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jacbts.2021.05.001","volume":"6","author":"V Cannone","year":"2021","unstructured":"Cannone V, Ledwidge M, Watson C, McKie PM, Burnett JC, McDonald K. STOP-HF trial. JACC Basic Transl Sci. 2021;6(6):497\u2013504. https:\/\/doi.org\/10.1016\/j.jacbts.2021.05.001.","journal-title":"JACC Basic Transl Sci"},{"issue":"8","key":"5610_CR12","first-page":"726","volume":"38","author":"HS Bello","year":"2021","unstructured":"Bello HS, Ogunmodede JA, Dele-Ojo BF, et al. Prognostic significance of Pre-Discharge plasma BNP among heart failure patients in Ilorin, Nigeria. West Afr J Med. 2021;38(8):726\u201331.","journal-title":"West Afr J Med"},{"issue":"4","key":"5610_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","volume":"72","author":"SJ Greene","year":"2018","unstructured":"Greene SJ, Butler J, Albert NM, et al. Medical therapy for heart failure with reduced ejection fraction. J Am Coll Cardiol. 2018;72(4):351\u201366. https:\/\/doi.org\/10.1016\/j.jacc.2018.04.070.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"5610_CR14","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/ejhf.2252","volume":"23","author":"J Butler","year":"2021","unstructured":"Butler J, Yang M, Sawhney B, Chakladar S, Yang L, Djatche LM. Treatment patterns and clinical outcomes among patients\u2009<\u200965 years with a worsening heart failure event. Eur J Heart Fail. 2021;23(8):1334\u201342. https:\/\/doi.org\/10.1002\/ejhf.2252.","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"5610_CR15","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.2165\/11319920-000000000-00000","volume":"69","author":"AD Szady","year":"2009","unstructured":"Szady AD, Hill JA. Diuretics in heart failure: A critical appraisal of efficacy and tolerability. Drugs. 2009;69(17):2451\u201361. https:\/\/doi.org\/10.2165\/11319920-000000000-00000.","journal-title":"Drugs"},{"issue":"1","key":"5610_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.15420\/ecr.2015.10.01.42","volume":"10","author":"G Casu","year":"2015","unstructured":"Casu G, Merella P, San Francesco Nuoro Hospital, Nuoro, Italy. Diuretic therapy in heart Failure \u2013 Current approaches. Eur Cardiol Rev. 2015;10(1):42. https:\/\/doi.org\/10.15420\/ecr.2015.10.01.42.","journal-title":"Eur Cardiol Rev"},{"issue":"1","key":"5610_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev-pharmtox-052120-014725","volume":"62","author":"KS Shah","year":"2022","unstructured":"Shah KS, Fang JC. Sodium-Glucose cotransporter 2 inhibitors in heart failure. Annu Rev Pharmacol Toxicol. 2022;62(1):109\u201320. https:\/\/doi.org\/10.1146\/annurev-pharmtox-052120-014725.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"5610_CR18","doi-asserted-by":"publisher","first-page":"1086672","DOI":"10.3389\/fcvm.2022.1086672","volume":"9","author":"TW Kao","year":"2022","unstructured":"Kao TW, Huang CC. Pleiotropic effect of sodium-glucose cotransporter 2 inhibitors on blood pressure. Front Cardiovasc Med. 2022;9:1086672. https:\/\/doi.org\/10.3389\/fcvm.2022.1086672.","journal-title":"Front Cardiovasc Med"},{"issue":"10367","key":"5610_CR19","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","volume":"400","author":"A Mebazaa","year":"2022","unstructured":"Mebazaa A, Davison B, Chioncel O, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial. Lancet. 2022;400(10367):1938\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(22)02076-1.","journal-title":"Lancet"},{"issue":"10","key":"5610_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s40266-015-0296-3","volume":"32","author":"TS Dharmarajan","year":"2015","unstructured":"Dharmarajan TS, Dharmarajan L. Tolerability of antihypertensive medications in older adults. Drugs Aging. 2015;32(10):773\u201396. https:\/\/doi.org\/10.1007\/s40266-015-0296-3.","journal-title":"Drugs Aging"},{"key":"5610_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejim.2024.12.034","volume":"134","author":"M Camafort","year":"2025","unstructured":"Camafort M, Kasiakogias A, Agabiti-Rosei E, et al. Hypertensive heart disease in older patients: considerations for clinical practice. Eur J Intern Med. 2025;134:75\u201388. https:\/\/doi.org\/10.1016\/j.ejim.2024.12.034.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"5610_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.47493\/abantmedj.1182158","volume":"11","author":"L A\u015fkin","year":"2022","unstructured":"A\u015fkin L, Tanriverdi\u0307 O. The benefits of Sacubitril-Valsartan in low ejection fraction heart failure. Bolu Abant Izzet Baysal Univ Tip Fak Abant Tip Derg. 2022;11(3):337\u2013336. https:\/\/doi.org\/10.47493\/abantmedj.1182158.","journal-title":"Bolu Abant Izzet Baysal Univ Tip Fak Abant Tip Derg"},{"issue":"39","key":"5610_CR23","doi-asserted-by":"publisher","first-page":"8765","DOI":"10.2174\/0109298673325682241114162014","volume":"32","author":"P Fountoulakis","year":"2025","unstructured":"Fountoulakis P, Kourampi I, Theofilis P, et al. Oxidative stress biomarkers in hypertension. Curr Med Chem. 2025;32(39):8765\u201382. https:\/\/doi.org\/10.2174\/0109298673325682241114162014.","journal-title":"Curr Med Chem"},{"issue":"4","key":"5610_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11897-017-0337-9","volume":"14","author":"S Van Linthout","year":"2017","unstructured":"Van Linthout S, Tsch\u00f6pe C. Inflammation \u2013 Cause or consequence of heart failure or both? Curr Heart Fail Rep. 2017;14(4):251\u201365. https:\/\/doi.org\/10.1007\/s11897-017-0337-9.","journal-title":"Curr Heart Fail Rep"},{"issue":"5","key":"5610_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","volume":"17","author":"L Adamo","year":"2020","unstructured":"Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2020;17(5):269\u201385. https:\/\/doi.org\/10.1038\/s41569-019-0315-x.","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"5610_CR26","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/nu17071250","volume":"17","author":"E Manta","year":"2025","unstructured":"Manta E, Iliakis P, Fragoulis C, et al. Tracking pathways linking obesity with heart failure. Nutrients. 2025;17(7):1250. https:\/\/doi.org\/10.3390\/nu17071250.","journal-title":"Nutrients"},{"issue":"2","key":"5610_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11897-015-0252-x","volume":"12","author":"AL Taylor","year":"2015","unstructured":"Taylor AL. Heart failure in women. Curr Heart Fail Rep. 2015;12(2):187\u201395. https:\/\/doi.org\/10.1007\/s11897-015-0252-x.","journal-title":"Curr Heart Fail Rep"},{"issue":"3","key":"5610_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/MNH.0000000000000404","volume":"27","author":"JF Reckelhoff","year":"2018","unstructured":"Reckelhoff JF. Gender differences in hypertension. Curr Opin Nephrol Hypertens. 2018;27(3):176\u201381. https:\/\/doi.org\/10.1097\/MNH.0000000000000404.","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-05610-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-05610-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T02:02:34Z","timestamp":1773799354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-05610-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5610"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-05610-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Civil Aviation General Hospital (2025-L-K-009) and complied with the Declaration of Helsinki. The requirement for written informed consent was waived by the ethics committee due to the retrospective nature of the study, which involved only de-identified patient data without any additional intervention or risk to participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain personal and\/or medical information about an identifiable living individual.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}